Interestingly, when SCC samples were treated with a TLR-7 agonist, imiquimod, tumor vessels up-regulated E-selectin expression causing an increase in CLA+ CD8+ T cell influx into the tumor, a decrease in Treg frequency and tumor regression. Here, TLR7 is linked to neoplasm.